Inventor · Leiden, NL

Jan Wouter Drijfhout

25Patents
4h-index
42Co-inventors
63Inventor score

Filing activity: Sep 15, 1997 → May 23, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US6274145A Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof Human Necessities 16 Expired
US10450356B2 PRAME derived peptides and immunogenic compositions comprising these Human Necessities 11 Active
US6723832B1 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof Human Necessities 6 Expired
US7888133B2 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit Emerging Cross-Sectional Technologies 5 Active
US8492514B2 PRAME derived peptides and immunogenic compositions comprising these Human Necessities 4 Active
US7993869B2 Method for detecting gluten Physics 4 Active
US9562085B2 Antimicrobial peptide Human Necessities 3 Active
US8481332B2 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit Emerging Cross-Sectional Technologies 3 Active
US9522962B2 Peptides, conjugates and method for increasing immunogenicity of a vaccine Human Necessities 2 Active
US8759114B2 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit Emerging Cross-Sectional Technologies 2 Active
US7115729B2 Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 Human Necessities 2 Expired
US7803756B2 Antimicrobial peptides derived from CAP18 Human Necessities 1 Active
US9829489B2 Compositions and methods for the diagnosis of rheumatoid arthritis Physics 1 Active
US9689871B2 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit Emerging Cross-Sectional Technologies 0 Active
US8541202B2 Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Emerging Cross-Sectional Technologies 0 Active
US8404647B2 Peptidylarginine deiminase (PAD) inhibitors Human Necessities 0 Active
US10684284B2 Compositions and methods for the diagnosis of rheumatoid arthritis Physics 0 Active
US8142786B2 Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Emerging Cross-Sectional Technologies 0 Active
US7807617B2 Peptide inhibitors of toxins derived from LL-37 Human Necessities 0 Expired
US9441025B2 Prame derived peptides and immunogenic compositions comprising these Human Necessities 0 Active
US12037372B2 Bioactive peptides derived from snakes Human Necessities 0 Active
US10130677B2 Antimicrobial peptide and uses thereof Emerging Cross-Sectional Technologies 0 Active
US10119966B2 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit Emerging Cross-Sectional Technologies 0 Active
US7888100B2 Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein Emerging Cross-Sectional Technologies 0 Active
US11680088B2 Bioactive peptides derived from snakes Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.